Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.

Bogenschutz MP, Ross S, Bhatt S, Baron T, Forcehimes AA, Laska E, Mennenga SE, O'Donnell K, Owens LT, Podrebarac S, Rotrosen J, Tonigan JS, Worth L

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (0)

No references identified in the available metadata. This does not establish that none exist.

    Cited by — these papers cite this paper (67)

    1. Changes in self-related cognitive processes and depressive symptom severity following a single, moderate dose of psilocybin in depressed patients 2026-11-10 · Expand citations
    2. High-Quality Genome Assembly and Transcriptomic Analysis Reveal Potential Pathways for Psilocybin Biosynthesis in Gymnopilus dilepis 2026-10-28 · Expand citations
    3. Clinical Evidence on Psilocybin and Its Representation in Media Reporting 2026-10-20 · Expand citations
    4. Efficacy and safety of psilocybin-assisted therapy for alcohol use disorder: A systematic review and meta-analysis 2026-10-08 · Expand citations
    5. Through the Looking-Glass: A Scoping Review of Psychological Mechanisms of Psychedelic-Assisted Therapy for Substance Use Disorders 2026-09-02 · Expand citations
    6. Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026) 2026-08-12 · Expand citations
    7. Psychedelic integration beyond the verbal: participatory-imaginal processing as a hypothesis-generating therapeutic framework 2026-08-12 · Expand citations
    8. Long- term administration of low doses of psilocybin causes epigenetic changes in the rat medial prefrontal cortex 2026-07-28 · Expand citations
    9. Integration in classic psychedelic-assisted therapies for mental health conditions: A scoping review 2026-07-26 · Expand citations
    10. Trajectories of psychedelic-assisted change: An observational study of a psilocybin retreat program followed by psychotherapeutic interventions 2026-07-03 · Expand citations
    11. Acceptability and safety of two sequential doses of psilocybin in bipolar II depression: protocol for an open-label single-arm feasibility study 2026-07-01 · Expand citations
    12. Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits 2026-07-01 · Expand citations
    13. Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults” 2026-06-30 · Expand citations
    14. Integrating psychedelic-assisted psychotherapy into addiction care in the Czech Republic: Clinical evidence, safety, and regulatory developments 2026-06-12 · Expand citations
    15. Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal Cortex 2026-06-01 · Expand citations
    16. Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations 2026-06-01 · Expand citations
    17. Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial 2026-06-01 · Expand citations
    18. Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headache 2026-05-29 · Expand citations
    19. Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder 2026-05-26 · Expand citations
    20. Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression 2026-05-15 · Expand citations
    21. Psilocybin in the Treatment of Cocaine Use Disorder 2026-05-07 · Expand citations
    22. Human brain changes after first psilocybin use 2026-05-05 · Expand citations
    23. Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression 2026-05-01 · Expand citations
    24. Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanisms 2026-05-01 · Expand citations
    25. Therapeutic Potential of Psilocybin in Alcohol and Opioid Use Disorders: A Promising Role for Psychedelics 2026-04-30 · Expand citations
    26. Psilocybin use in Puerto Rico: Patterns, motivations, and personality correlates from an online survey 2026-04-15 · Expand citations
    27. Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications 2026-04-01 · Expand citations
    28. Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons 2026-03-27 · Expand citations
    29. Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD) 2026-03-26 · Expand citations
    30. Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies 2026-03-19 · Expand citations
    31. Psilocybin retail stores in Canada: Changes in availability, commercialization, and geographic distribution 2026-03-19 · Expand citations
    32. Synthesis and Characterization of Psilocybin Metabolites and Deuterated Analogs 2026-03-18 · Expand citations
    33. Psilocybin or Nicotine Patch for Smoking Cessation 2026-03-10 · Expand citations
    34. Psilocybin and Ibogaine in Cocaine-Seeking: Extinction Enhancement Without Relapse Prevention 2026-03-01 · Expand citations
    35. A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations 2026-02-28 · Expand citations
    36. THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS 2026-01-22 · Expand citations
    37. Psychedelic-assisted psychotherapy: Clarifying the role of the "psychotherapy" 2026-01-01 · Expand citations
    38. Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational Study 2025-12-19 · Expand citations
    39. The Psychedelic Psilocin Suppresses Activity of Central Amygdala Corticotropin-Releasing Factor Receptor 1 Neurons and Decreases Ethanol Drinking in Female Mice 2025-12-10 · Expand citations
    40. Psychedelics for the Treatment of Substance Use Disorders 2025-12-01 · Expand citations
    41. Three Cases of Depersonalization/Derealization Disorder Related to the Use of Classic Psychedelics 2025-12-01 · Expand citations
    42. Self-reported improvement in depression, anxiety, and substance use in Spanish-speakers after a memorable psychedelic experience 2025-11-20 · Expand citations
    43. Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case Report 2025-09-01 · Expand citations
    44. Increasing the Evaluation and Reporting Rigor of Psychotherapy Interventions in Treatments Involving Psychedelics 2025-06-29 · Expand citations
    45. Evaluating the Effectiveness of Psychedelic-Assisted Therapy in Treating Alcohol Use Disorders: A Review 2025-05-02 · Expand citations
    46. Improving Best Practice Indicators for Psilocybin Assisted Therapy Using a Mul-tiphase Mixed Methods Delphi Study 2025-04-30 · Expand citations
    47. University Students’ Motives for Psilocybin Use: A Mixed-Methods Analysis 2025-04-26 · Expand citations
    48. Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile Analysis 2025-04-24 · Expand citations
    49. Psychedelics for Substance Use Disorders: Updates for the Psychiatric Trainee 2025-03-06 · Expand citations
    50. Psilocybin: revealing the enigmas of a revolutionary fungi 2025-01-01 · Expand citations
    51. An Early Exploration into Individuals in Treatment Who Co-Use Alcohol and Hallucinogens 2024-10-15 · Expand citations
    52. The Psychedelic Renaissance: A Catholic Perspective 2024-09-14 · Expand citations
    53. An estimate of the number of people with clinical depression eligible for psilocybin-assisted therapy in the United States 2024-09-13 · Expand citations
    54. Insights into the efficacy of psilocybin in treating depression and other disorders 2024-08-01 · Expand citations
    55. From chaos to kaleidoscope: Exploring factors in psychedelic self-treatment for mental health conditions 2024-07-28 · Expand citations
    56. Assessment of psychedelic--induced states: Norwegian translation and adaptation of the revised Mystical Experience Questionnaire (MEQ-30) 2024-07-12 · Expand citations
    57. Psilocybin in the Management of Substance Use Disorders: A Summary ofCurrent Evidence 2024-07-04 · Expand citations
    58. Therapeutic Implications of Psilocybin in the Wake of Decriminalization 2024-06-01 · Expand citations
    59. Managing expectations with psychedelic microdosing 2023-11-08 · Expand citations
    60. Pharmacists’ perspectives on psilocybin in Canada 2023-11-08 · Expand citations
    61. Psilocybin-assisted psychotherapy for the treatment of PTSD in UK armed forces veterans: A feasibility study protocol 2023-10-25 · Expand citations
    62. Can a single dose of psilocybin improve cognitive control in functional dissociative seizures? 2023-09-09 · Expand citations
    63. use of psilocybin in the treatment of psychiatric disorders - review 2023-08-15 · Expand citations
    64. A suicide attempt following psilocybin ingestion in a patient with no prior psychiatric history 2023-04-26 · Expand citations
    65. The therapeutic potential of psychedelics: the European regulatory perspective 2023-02-10 · Expand citations
    66. Effects of a single dose of psilocybin on cytokines, chemokines and leptin in rat serum 2022-12-07 · Expand citations
    67. Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects 2022-12-01 · Expand citations